Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Gene Therapy
New cancer gene therapy research from Mount Sinai School of Medicine, Department of Medicine discussed
June 30th, 2009
Research findings, 'Genetically engineered Newcastle disease virus for malignant melanoma therapy,' are discussed in a new report. According to recent research published in the journal Gene Therapy, "Despite the advances in cancer therapies in the past century, malignant melanoma continues to present a significant clinical challenge due to lack of chemotherapeutic response. Systemic therapy with immunostimulatory agents such as interferon and interleukin-2 (IL-2) has shown some promise, though each is associated with significant side effects." "Over the past 50 years, oncolytic Newcastle disease virus (NDV) has emerged as an alternative candidate for cancer...
Source: Cancer Weekly (2009-06-30)
|
